Black Rock Inc. Galecto, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Galecto, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 21,205 shares of GLTO stock, worth $143,769. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,205
Previous 51,025
58.44%
Holding current value
$143,769
Previous $39,000
76.92%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding GLTO
# of Institutions
13Shares Held
442KCall Options Held
100Put Options Held
100-
Susquehanna International Group, LLP Bala Cynwyd, PA168KShares$1.14 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il129KShares$871,7990.0% of portfolio
-
Bank Of America Corp Charlotte, NC30.6KShares$207,2170.0% of portfolio
-
Virtu Financial LLC New York, NY14.7KShares$99,5160.0% of portfolio
-
Morgan Stanley New York, NY3KShares$20,3400.0% of portfolio
About Galecto, Inc.
- Ticker GLTO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,395,700
- Market Cap $172M
- Description
- Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clini...